Financial statements Bio Innovative Technology

Balance sheet of Bio Innovative Technology

Company age:
Age:
11 y. 7 d.
Share capital:
Share capital:
50 000 PLN

Balance sheet data of BIO INNOVATIVE TECHNOLOGY

Year
2018
2019
2020
2021
2022
2023
Total assets 167 581,29 163 231,76 126 747,70 138 499,91 115 712,05 104 656,04
A. Fixed assets 1 775,20 760,80 0,00 7 803,00 5 967,00 4 131,00
B. Current assets 165 806,09 162 470,96 126 747,70 130 696,91 109 745,05 100 525,04
C. Share capital contributions (basic funds) 0,00 0,00 - - - -
D. Own shares (stocks) 0,00 0,00 - - - -
Total liabilities 167 581,29 163 231,76 126 747,70 138 499,91 115 712,05 104 656,04
A. Equity 113 203,61 129 924,11 112 702,03 115 782,48 105 554,73 94 930,55
B. Liabilities and provisions for liabilities 54 377,68 33 307,65 14 045,67 22 717,43 10 157,32 9 725,49
I. Long-term liabilities - - - - - -
II. Short-term liabilities - - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.